Kazue Takai Selected Research

Multi-centric Castleman's Disease

5/2022	TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
8/2021	Patient's age and D-dimer levels predict the prognosis in patients with TAFRO syndrome.
1/2021	Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan.
3/2019	An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
1/2019	Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
1/2018	The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
1/2017	Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.
6/2016	Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.
2/2016	Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazue Takai Research Topics

Disease

11	Edema (Dropsy) 05/2022 - 05/2010
11	Fever (Fevers) 05/2022 - 05/2010
11	Thrombocytopenia (Thrombopenia) 05/2022 - 05/2010
9	Multi-centric Castleman's Disease 05/2022 - 02/2016
8	Fibrosis (Cirrhosis) 05/2022 - 05/2010
3	Castleman Disease (Castleman's Disease) 03/2022 - 01/2018
3	Primary Myelofibrosis (Myelosclerosis) 08/2021 - 01/2019
3	Renal Insufficiency (Renal Failure) 10/2019 - 01/2018
3	Lymphoma (Lymphomas) 05/2010 - 07/2003
2	Multiple Organ Failure (MODS) 01/2013 - 05/2010
2	Pleural Effusion (Pleural Effusions) 01/2013 - 10/2004
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 03/2019
1	Hypoalbuminemia 01/2019
1	Anemia 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 02/2016
1	Abdominal Pain (Pain, Abdominal) 02/2016
1	Disease Progression 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Oliguria 01/2013
1	Pancytopenia 01/2012
1	Portal Hypertension 01/2012
1	Autoimmune Hepatitis 01/2012
1	Acute Promyelocytic Leukemia 01/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2011
1	Takotsubo Cardiomyopathy 12/2011
1	Cardiogenic Shock 12/2011
1	Hematologic Neoplasms (Hematological Malignancy) 12/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2011
1	Graves Disease (Basedow Disease) 01/2011
1	Evans Syndrome 01/2011
1	Lymphadenopathy 05/2010
1	Chronic Hepatitis B 09/2005
1	Hepatitis 09/2005
1	Massive Hepatic Necrosis 09/2005
1	Infections 09/2005
1	POEMS Syndrome (Syndrome, POEMS) 10/2004
1	Demyelinating Diseases (Demyelinating Disease) 10/2004
1	Duodenal Ulcer (Curling's Ulcer) 07/2003
1	Necrosis 07/2003
1	Peritonitis 07/2003
1	Liver Diseases (Liver Disease) 07/2003

Drug/Important Bio-Agent (IBA)

11	Reticulin (Reticular Fiber)IBA 05/2022 - 05/2010
4	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2018
3	SteroidsIBA 01/2013 - 05/2010
2	CytokinesIBA 01/2017 - 07/2003
2	tocilizumab (atlizumab)FDA Link 06/2016 - 01/2013
1	fibrin fragment D (D-dimer)IBA 08/2021
1	C-Reactive ProteinIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	InterferonsIBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2016
1	GlucocorticoidsIBA 06/2016
1	Rituximab (Mabthera)FDA Link 06/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2016
1	Alkaline PhosphataseIBA 02/2016
1	AutoantibodiesIBA 01/2013
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2012
1	Imatinib Mesylate (Gleevec)FDA Link 03/2011
1	Propylthiouracil FDA Link 01/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2011
1	Thyroglobulin FDA Link 01/2011
1	Lamivudine (Epivir)FDA Link 09/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2004
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2004
1	Melphalan (Alkeran)FDA LinkGeneric 10/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2003
1	Granzymes (Granzyme)IBA 07/2003

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2012 - 07/2003
5	Therapeutics 01/2012 - 10/2004
1	Renal Dialysis (Hemodialysis) 01/2013
1	VAP-cyclo protocol 05/2010
1	Chest Tubes (Chest Tube) 10/2004
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2004